This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Related letters  • Similar articles in JAMA  Topic Collections  • Aging/ Geriatrics  • Cardiovascular Interventions, Other  • Cardiovascular System  • Prognosis/ Outcomes  • Congestive Heart Failure/ Cardiomyopathy  • Cardiovascular Intervention  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The study by Dr Hernandez and colleagues¹ reported on outcomes of ventricular assist device recipients by analyzing claims from the Centers for Medicare & Medicaid Services from 2000 to 2006. They reported a 1-year survival of 51.6% for the primary device group and 30.8% for the postcardiotomy group. Given the introductory comments as well as numerous references to the REMATCH trial² and the 50% 2-year survival benchmark set by the National Heart, Lung, and Blood Institute Working Group for destination therapy (the use of ventricular assist devices in patients who are not candidates for cardiac transplantation),³ we are concerned that this analysis does not represent the current state of destination therapy in the Medicare population. As the authors state in their limitations section, their analysis reflects the use of a large variety of devices ranging from percutaneous external devices to long-term implantable devices used for destination therapy. . . . [Full Text of this Article]

Daniel B. Sims, MD
das9093@nyp.org
Division of Cardiology

Yoshifumi Naka, MD, PhD
Division of Cardiothoracic Surgery

Ulrich P. Jorde, MD
Division of Cardiology
Columbia University Medical Center
New York, NY

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Long-term Outcomes and Costs of Ventricular Assist Devices Among Medicare Beneficiaries
Adrian F. Hernandez, Alisa M. Shea, Carmelo A. Milano, Joseph G. Rogers, Bradley G. Hammill, Christopher M. O’Connor, Kevin A. Schulman, Eric D. Peterson, and Lesley H. Curtis
JAMA. 2008;300(20):2398-2406.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Outcomes of Medicare Beneficiaries With Ventricular Assist Devices
Leslie W. Miller
JAMA. 2009;301(16):1656-1657.
EXTRACT | FULL TEXT  

Outcomes of Medicare Beneficiaries With Ventricular Assist Devices
Mark S. Slaughter
JAMA. 2009;301(16):1657-1658.
EXTRACT | FULL TEXT  

Outcomes of Medicare Beneficiaries With Ventricular Assist Devices—Reply
Adrian F. Hernandez, Bradley G. Hammill, and Lesley H. Curtis
JAMA. 2009;301(16):1658.
EXTRACT | FULL TEXT